Contrast‐Enhanced Sonography Depicts Spontaneous Ovarian Cancer at Early Stages in a Preclinical Animal Model

Our goal was to examine the feasibility of using laying hens, a preclinical model of human spontaneous ovarian cancer, in determining the kinetics of an ultrasound contrast agent indicative of ovarian tumor‐associated neoangiogenesis in early‐stage ovarian cancer.

[1]  I. Damjanov.  Ovarian tumours in laboratory and domestic animals. , 1989, Current topics in pathology. Ergebnisse der Pathologie.

[2]  P. Bitterman,et al.  Detection of Tumor‐Associated Neoangiogenesis by Doppler Ultrasonography During Early‐Stage Ovarian Cancer in Laying Hens , 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[3]  D. Fishman,et al.  Diagnostic Parameters to Differentiate Benign From Malignant Ovarian Masses With Contrast‐Enhanced Transvaginal Sonography , 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[4]  M. Ordén,et al.  Intravascular ultrasound contrast agent: an aid in imaging intervillous blood flow? , 1999, Placenta.

[5]  Diljeet Singh,et al.  The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. , 2005, American journal of obstetrics and gynecology.

[6]  E. Leen.  Ultrasound contrast harmonic imaging of abdominal organs. , 2001, Seminars in ultrasound, CT, and MR.

[7]  M. Ordén,et al.  Contrast‐enhanced sonography in the examination of benign and malignant adnexal masses. , 2000, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[8]  Philippe Shubik,et al.  Vascularization of tumors: A review , 2004, Journal of Cancer Research and Clinical Oncology.

[9]  R. Osmers,et al.  Visualization of blood flow in small ovarian tumor vessels by transvaginal color Doppler sonography after echo enhancement with injection of Levovist. , 1994, Gynecologic and obstetric investigation.

[10]  Jean-François Ethier,et al.  Reproductive Biology and Endocrinology Open Access Animal Models of Ovarian Cancer , 2022 .

[11]  B. Giraudeau,et al.  Contrast‐Enhanced Sonography Helps in Discrimination of Benign From Malignant Adnexal Masses , 2004, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[12]  P. Bitterman,et al.  Histopathology of Ovarian Tumors in Laying Hens: A Preclinical Model of Human Ovarian Cancer , 2009, International Journal of Gynecologic Cancer.

[13]  M. Urick,et al.  VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. , 2008, Gynecologic oncology.

[14]  Richard G. Moore,et al.  How do you distinguish a malignant pelvic mass from a benign pelvic mass? Imaging, biomarkers, or none of the above. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Lee,et al.  Microvessel quantitation and prognosis in invasive breast carcinoma. , 1992, Human pathology.

[16]  M. Geller,et al.  Angiogenesis in normal and neoplastic ovaries , 2005, Angiogenesis.

[17]  F Forsberg,et al.  Artifacts in ultrasonic contrast agent studies. , 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[18]  D. B. Hales,et al.  Cyclooxygenases expression and distribution in the normal ovary and their role in ovarian cancer in the domestic hen (Gallus domesticus) , 2008, Endocrine.

[19]  P. Mozdziak,et al.  CA125 expression in spontaneous ovarian adenocarcinomas from laying hens. , 2007, Gynecologic oncology.

[20]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[21]  P. Bitterman,et al.  Detection of Ovarian Tumors in Chicken by Sonography , 2007, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[22]  T. Fredrickson.  Ovarian tumors of the hen. , 1987, Environmental health perspectives.

[23]  D. Fishman,et al.  Contrast‐Enhanced Transvaginal Sonography of Benign Versus Malignant Ovarian Masses , 2008, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[24]  M. Fukumoto,et al.  Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor. , 2000, Anticancer research.

[25]  M. Neeman,et al.  Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[27]  M. Hellmich,et al.  Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study. , 2006, Gynecologic oncology.

[28]  Fathalla Mf.  Incessant ovulation--a factor in ovarian neoplasia? [letter] , 1971 .

[29]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[30]  J. Jurvelin,et al.  Kinetics of a US contrast agent in benign and malignant adnexal tumors. , 2003, Radiology.

[31]  C. Perrett,et al.  Angiogenesis in epithelian ovarian cancer , 2002, Molecular pathology : MP.

[32]  Rodent models for ovarian cancer research , 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[33]  M. Fukumoto,et al.  Expression of thymidine phosphorylase in epithelial ovarian cancer: correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity. , 2000, Gynecologic oncology.

[34]  W. Grizzle,et al.  Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention. , 2001, Gynecologic oncology.

[35]  M F Fathalla,et al.  Incessant ovulation--a factor in ovarian neoplasia? , 1971, Lancet.